2024-07-03 07:03:01 ET
Summary
- FTC sues to block Tempur Sealy's $4B purchase of Mattress Firm, alleging potential market domination and price increases.
- Rivian denies rumors of expanding partnership with Volkswagen for vehicle production.
- Eli Lilly wins FDA approval for donanemab as a treatment for Alzheimer's.
Listen below or on the go on Apple Podcasts and Spotify
FTC sues to block Tempur Sealy's ( TPX ) $4B purchase of Mattress Firm. (00:23) EV maker Rivian ( RIVN ) has no production plans with Volkswagen - report. (01:42) Eli Lilly ( LLY ) wins FDA approval of donanemab for Alzheimer's. (02:27)...
Read the full article on Seeking Alpha
For further details see:
Wall Street Breakfast Podcast: FTC Moves To Block Tempur Sealy's $4B Mattress Firm Deal